Am J Transplant, Volume 22, Suppl 3 Archives - Page 72 of 190 - ATC Abstracts

2022 American Transplant Congress
Failure to Account for Social Determinants of Health in Non-HCC MELD Exceptions Exacerbates Geographic Disparities in Access to Liver Transplantation
R. M. Cannon, P. MacLennan, S. S. Sheikh, B. J. Orandi, A. Nasell, J. T. Walker, J. E. Locke
University of Alabama at Birmingham, Birmingham, AL
*Purpose: Non-HCC MELD exceptions have been previously shown to give excess priority for transplant in certain UNOS Regions, but this phenomenon has not been examined…
2022 American Transplant Congress
Liver Transplantation for Patients with Fibrolamellar Hepatocellular Carcinoma: A Comprehensive Multicenter Analysis to Support Future Decision Making
M. P. Claasen¹, T. Ivanics¹, W. G. Polak², J. N. IJzermans², G. Sapisochin¹
¹Multi-Organ Transplant Program, University Health Network, Toronto, ON, Canada, ²HPB and Transplant Surgery, Erasmus MC, Rotterdam, Netherlands
*Purpose: Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare tumour accounting for ~1% of all primary liver cancers. Due to its rarity, there is a shortage…
2022 American Transplant Congress
Metabolic Outcomes After Pancreas Transplant Alone from Donation After Circulatory Death Donor – The UK Registry Analysis
J. Gopal, A. McLean, A. Muthusamy
Imperial College Renal and Transplant Center, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
*Purpose: Extrapolating data from early DCD (donation after circulatory death) kidney transplantation, pancreas transplants from DCD grafts were feared to have worse metabolic outcomes. Hence,…
2022 American Transplant Congress
Ultrasound Targeted Microbubble Cavitation During Ex Vivo Normothermic Machine Perfusion Reduces Peribiliary Vascular Plexus Thrombi and Graft Injury in a DCD Liver Transplant Model
Y. Nigmet¹, C. Hughes¹, X. Chen², A. Demetris³, D. Stolz⁴, J. Pacella², A. Humar⁵, F. Villanueva²
¹Transplant Surgery, University of Pittsburgh, Pittsburgh, PA, ²Center for Ultrasound Molecular Imaging and Therapeutics, University of Pittsburgh, Pittsburgh, PA, ³Transplant Pathology, University of Pittsburgh, Pittsburgh, PA, ⁴Center for Biological Imaging, University of Pittsburgh, Pittsburgh, PA, ⁵Thomas E Starzl Transplant Inst, Pittsburgh, PA
*Purpose: Thrombus formation in the peribiliary vascular plexus (PBP) is a proposed mechanism for ischemic cholangiopathy (IC) after liver transplantation from donors after circulatory death…
2022 American Transplant Congress
Outcomes of Sensitized Simultaneous Liver-Kidney Transplant
E. R. Kitchel, T. Tan, A. Wadhwa, D. G. Farmer, S. Bunnapradist
David Geffen School of Medicine, Los Angeles, CA
*Purpose: Pre-formed donor-specific HLA antibodies (DSAs) in simultaneous liver-kidney transplants (SLKTs) have been associated with increased risk of antibody mediated rejection (AMR) and negative transplant…
2022 American Transplant Congress
Clinical Significances Of Anti-collagen Type I And Type Iii Antibodies In Antibody-mediated Rejection
S. Park¹, S. Yang¹, K. Moon¹, J. Ha¹, Y. Kim¹, E. Song¹, H. Lee²
¹Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, ²Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: It is important to determine the clinical significance of non-human leukocyte antigen (HLA) antibodies and their association with antibody-mediated rejection (ABMR) of kidney allografts.*Methods:…
2022 American Transplant Congress
Successful Outcome of Highly Sensitized Patients After Heart Transplantation Under RATG Regimen
G. Esmailian, T. Singer-Englar, J. Patel, M. Kittleson, S. Kim, N. Patel, D. Chang, E. Kransdorf, F. Esmailian, J. A. Kobashigawa
Cedars-Sinai Smidt Heart Institute, Los Angeles, CA
*Purpose: Highly sensitized patients (panel reactive antibody [PRA] ≥50%) are known to be at risk for poor outcome after heart transplantation (HTx). In our program,…
2022 American Transplant Congress
Impacts Of Donor Gender On Recurrent Hepatocellular Carcinoma In Liver Transplant Donated After Brain Death
T. Nakamura¹, K. Sasaki², T. Yamamoto¹, S. Kimura¹, L. Dageforde¹, H. Yeh¹, N. Elias¹, T. Kawai¹, J. F. Markmann¹
¹Division of Transplant Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ²Division of Abdominal Transplantation, Stanford University, Stanford, CA
*Purpose: Hepatocellular carcinoma (HCC) is the most common form of primary liver cancer. It is well known that HCC is predominant in males and prognosis…
2022 American Transplant Congress
Pre-Vaccine Antibodies Against Seasonal Betacoronaviruses Are Associated with Decreased Antibody Response to SARS-CoV-2 mRNA Vaccination in Solid Organ Transplant Recipients
A. Karaba¹, W. Zhou¹, T. Aytenfisu¹, T. S. Johnston¹, O. Akinde¹, Y. Eby¹, A. Abedon¹, J. Alejo¹, C. Qin¹, J. Garonzik-Wang², S. Klein¹, J. Bailey¹, A. Cox¹, J. Blankson¹, D. Segev¹, A. Tobian¹, W. Werbel¹
¹Johns Hopkins University, Baltimore, MD, ²University of Wisconsin School of Medicine and Health, Madison, WI
*Purpose: The impact of antigenic imprinting, when immune memory of one antigen influences the response to subsequent similar antigens, on the antibody response in solid…
2022 American Transplant Congress
Knowledge, Attitude, and Practices Regarding Covid-19 Among Solid Organ Transplant Patients at a Transplant Center in the United States: A Cross-Sectional Study
L. Wang, H. Oduor, M. Abualfoul, P. Acharya, M. Pagadala
Methodist Dallas Medical Center, Dallas, TX
*Purpose: To evaluate the knowledge, attitude, and practices (KAP) of patients who have undergone kidney and/or liver solid organ transplants (SOTs) during the COVID-19 pandemic.*Methods:…